Mountain View, CA / Berlin, Germany
We are happy to announce Dr. Ruby Yanru Chen-Tsai, Co-founder and Chief Scientific Officer at Applied StemCell, Inc. as a speaker for the 2019 Undoing Aging Conference.
Dr. Chen-Tsai received her PhD from Cornell University and did her post-doc research at Stanford University. She has been doing research in genome editing and stem cells over 20 years. Prior to joining ASC, Dr. Chen-Tsai worked at Stanford University for 16 years as the Director of Transgenic Research Center and Associate Director of the Stanford Cancer Institute, overseeing nine research technology labs. Her research at Stanford focused on using Parkinson patient-specific iPS cell lines and their differentiation to dopaminergic neurons as a disease model-in-a-dish. She is a co-inventor of the TARGATT™ integrase technology for site-specific gene insertion.
Dr. Chen-Tsai is an author of many scientific papers and holder of over fifteen patents. Dr. Chen-Tsai is currently leading Applied StemCell's therapeutic pipeline with a strong focus on monogenic blood disorders that are characterized by high genetic penetrance.
"Ruby, along with her company Applied Stem Cell, is one of the world’s most respected experts in gene editing. We are delighted to be working with her on our ambitious project to transform the potential of somatic gene therapy, in terms of both its safety from creating unwanted mutations and its efficacy in delivering large amounts of DNA, which is founded on some pioneering work at Stanford in which she was also heavily involved." says Aubrey de Grey.
"Innovation has to be based on solid science.” says Ruby Chen-Tsai.